Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 170.22 billion. The enterprise value is 272.51 billion.
| Market Cap | 170.22B | 
| Enterprise Value | 272.51B | 
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
Amicogen has 55.27 million shares outstanding. The number of shares has increased by 15.62% in one year.
| Current Share Class | 55.27M | 
| Shares Outstanding | 55.27M | 
| Shares Change (YoY) | +15.62% | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 4.90% | 
| Owned by Institutions (%) | 4.09% | 
| Float | 49.80M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 1.45 | 
| PB Ratio | 1.42 | 
| P/TBV Ratio | 1.64 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -5.49 | 
| EV / Sales | 2.31 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | -6.48 | 
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.96.
| Current Ratio | 0.75 | 
| Quick Ratio | 0.47 | 
| Debt / Equity | 0.96 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | -2.75 | 
| Interest Coverage | -1.28 | 
Financial Efficiency
Return on equity (ROE) is -28.99% and return on invested capital (ROIC) is -2.37%.
| Return on Equity (ROE) | -28.99% | 
| Return on Assets (ROA) | -2.01% | 
| Return on Invested Capital (ROIC) | -2.37% | 
| Return on Capital Employed (ROCE) | -6.44% | 
| Revenue Per Employee | 498.82M | 
| Profits Per Employee | -210.31M | 
| Employee Count | 236 | 
| Asset Turnover | 0.32 | 
| Inventory Turnover | 2.91 | 
Taxes
| Income Tax | -918.88M | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -35.11% in the last 52 weeks. The beta is 0.61, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 | 
| 52-Week Price Change | -35.11% | 
| 50-Day Moving Average | 3,639.40 | 
| 200-Day Moving Average | 3,726.25 | 
| Relative Strength Index (RSI) | 24.81 | 
| Average Volume (20 Days) | 236,262 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, Amicogen had revenue of KRW 117.72 billion and -49.63 billion in losses. Loss per share was -902.26.
| Revenue | 117.72B | 
| Gross Profit | 30.06B | 
| Operating Income | -11.96B | 
| Pretax Income | -49.37B | 
| Net Income | -49.63B | 
| EBITDA | -185.11M | 
| EBIT | -11.96B | 
| Loss Per Share | -902.26 | 
Balance Sheet
The company has 23.83 billion in cash and 115.57 billion in debt, giving a net cash position of -91.73 billion or -1,659.83 per share.
| Cash & Cash Equivalents | 23.83B | 
| Total Debt | 115.57B | 
| Net Cash | -91.73B | 
| Net Cash Per Share | -1,659.83 | 
| Equity (Book Value) | 119.97B | 
| Book Value Per Share | 1,996.09 | 
| Working Capital | -17.38B | 
Cash Flow
In the last 12 months, operating cash flow was -28.74 billion and capital expenditures -13.29 billion, giving a free cash flow of -42.03 billion.
| Operating Cash Flow | -28.74B | 
| Capital Expenditures | -13.29B | 
| Free Cash Flow | -42.03B | 
| FCF Per Share | -760.46 | 
Margins
Gross margin is 25.54%, with operating and profit margins of -10.16% and -42.16%.
| Gross Margin | 25.54% | 
| Operating Margin | -10.16% | 
| Pretax Margin | -41.94% | 
| Profit Margin | -42.16% | 
| EBITDA Margin | -0.16% | 
| EBIT Margin | -10.16% | 
| FCF Margin | n/a | 
Dividends & Yields
Amicogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -15.62% | 
| Shareholder Yield | -15.62% | 
| Earnings Yield | -29.16% | 
| FCF Yield | -24.69% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 | 
| Split Type | Forward | 
| Split Ratio | 2 | 
Scores
Amicogen has an Altman Z-Score of 0.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 | 
| Piotroski F-Score | 2 |